Qualigen therapeutics announces ind-enabling studies to advance lead program qn-302 toward clinical trials

A p otential t reatment for pancreatic cancer in a ddition to o ther t umors of h igh u nmet c linical n eed

QLGN Ratings Summary

QLGN Quant Ranking